Cargando…
Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
Background: Evidence of osimertinib as neoadjuvant therapy for resectable non-small cell lung cancer (NSCLC) are currently lacking. This case series study aimed to assess the safety and feasibility of neoadjuvant osimertinib therapy followed by surgery for resectable NSCLC. Materials and methods: Pa...
Autores principales: | Hu, Yan, Ren, Siying, Yang, Lulu, Tong, Zhongyi, Wang, Ruoyao, Han, Wei, Zeng, Chao, Li, Jina, Xiao, Peng, Wang, Li, Yu, Fenglei, Liu, Wenliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096023/ https://www.ncbi.nlm.nih.gov/pubmed/35571073 http://dx.doi.org/10.3389/fphar.2022.912153 |
Ejemplares similares
-
Case Report: Pathological Complete Response to Neoadjuvant Alectinib in a Patient With Resectable ALK-Positive Non-Small Cell Lung Cancer
por: Hu, Yan, et al.
Publicado: (2022) -
Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
por: Liu, Wenliang, et al.
Publicado: (2022) -
The predictive role of hematologic markers in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy: a retrospective cohort study
por: Liu, Wenliang, et al.
Publicado: (2023) -
Case Report: Uniportal Video-Assisted Thoracoscopic Parenchymal Sparing Secondary Carinal Resection and Reconstruction for the Treatment of Tracheobronchial Mucoepidermoid Carcinoma
por: Hu, Yan, et al.
Publicado: (2022) -
Case Report: Surgical Therapy for Left Innominate Vein Aneurysm Under Thoracoscopy
por: Hu, Yan, et al.
Publicado: (2021)